MedTech news
Americas
Law firm White & Case has hired Charles Larsen as a partner in its global intellectual property practice in Boston. 23 September 2016
Europe
A decision by Germany’s Federal Court of Justice has developed the concept of the ‘doctrine of equivalents’, possibly benefiting pharma patent owners, say Bernd Allekotte and Markus Grammel of Grünecker. 20 September 2016
Pharma
Ahead of the Life Sciences IP Summit 2016 from October 20 to 21 at the Hilton London Paddington Hotel, Sarah Porch of C5 previews the main talking points, including Brexit and the UPC. 16 September 2016
Pharma
The pharmaceutical industry needs to adjust its expectations of the scope of IP protection available in the digital age, say Stephen Bennett, Elisabethann Wright and Mark Marfe of Hogan Lovells, and James Cross of RGC Jenkins. 13 September 2016
Europe
Brexit will have significant consequences for the UK regarding SPCs and the unitary patent system, while the UPC’s proposed start date of early 2017 looks highly unlikely, say Christopher Stothers and Paul Abbott of Arnold & Porter. 6 September 2016
Pharma
The Francis Crick Institute, Europe’s biggest biomedical research institute, has opened in London. 5 September 2016
Americas
Diagnostics company Alere has filed a complaint against Abbott in the Delaware Chancery Court in an attempt to compel Abbott to fulfil its obligations surrounding the companies’ merger agreement. 31 August 2016
Americas
The US Supreme Court’s Mayo and Myriad decisions have brought challenges to subject matter eligibility to the forefront in the biomedical industry, but they do not signal the end of biomedical patents. Pat Carson and Mira Atanassova Mulvaney of Kirkland & Ellis report. 18 August 2016
Americas
Law firm Akerman has hired Thomas Pasternak in the intellectual property practice group in Chicago. 2 August 2016
Americas
The Brazilian Federal Prosecutor’s Office has taken court action against Roche for allegedly abusing IP rights in its sales of Herceptin to state governments. Anderson Ribeiro and Ricardo Campello of Provedel Advogados analyse the case. 2 August 2016